Page results
-
This information booklet explains the treatment of overactive bladder syndrome using injections of Botulinum toxin (BOTOX®) into the bladder wall.
-
Patients are referred to UCLH for plasma exchange, which we can do day or night. This involves removing plasma and replacing with donor plasma using a machine. This procedure is not painful.…
-
Haematology Cancer Care celebrates its 30th year in 2024, having been supported by patients and staff over the past three decades because we help the Haematology Service to deliver…
-
First appointments If you are a patient and want to change or cancel a first appointment in the service please contact the patient booking team on 0203 448 4777. Cancellations We understand…
-
Emily Pride’s world turned upside down when, at 14, she was diagnosed with a string of painful and life-changing conditions. She tells us how UCLH’s complex pain team gave back her life.
-
This page will give you an overview of intravesical thermo-chemotherapy, how it is given and side effects it may cause.
-
This page will give you an overview of intravesical chemotherapy, how it is given and side effects it may cause.
-
This page will give you an overview of intravesical RF induced thermochemotherapy, how it is given and side effects it may cause.
-
This page will give you an overview of intravesical chemotherapy, how it is given and side effects it may cause.
-
Please visit the individual children and young people's services pages for specific contact and referral information. The information below is general contact information for the children…
File results
-
Council of Governors meeting papers - 31 October
-
Consultant - to -consultant referral form
-
UCLH Provider to Provider Tariff 2019-20
-
What young people would like everyone to know about Type 1 Diabetes
-
Reverse mentoring
-
FOI/2020/0572 - Inflamatory bowel disease staff contact details
-
FOI2017294 Contactors and subcontractors working on the Phase 4 and proton therapy beam
-
FOI/2020/0589 - Senior staff contacts for CEO, Director of Innovation and Chief Pharmacist
-
FOI/2020/0630 - CEO, Operations Director and Health and Safety Director contact details
-
FOI2017333 Midwifery contacts for accessing return to practice placements